BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, March 29, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Nov. 19, 2020
View Archived Issues
'Superkiller' is broad-spectrum antiviral target
Read More
CDK4/6 inhibitors affect transcriptional landscape
Read More
PTC Therapeutics initiates phase I study of PTC-518
Read More
Intermittent schedule of CH-5126766 shows activity across several RAS-RAF-driven cancers
Read More
Peptide-conjugated ReNcell-derived EVs: a new therapeutic approach for pulmonary hypertension
Read More
Phase I data presented for AMG-890 in patients with elevated plasma Lp(a)
Read More
Neuro-drug repurposed to treat MDR Gram-negative sepsis
Read More
Pionyr initiates phase I study of its immuno-oncology candidate, PY-314
Read More
Phase II/III CAPELLA study of lenacapavir meets primary endpoint
Read More
First-in-human biomarker analysis for JNJ-55920839 in SLE
Read More
University of Kansas, Fox Chase Cancer Center describe anti-CTLA-4 antibodies
Read More
Yeda Research & Development patents polypeptides comprising propeptides of human lysyl oxidase
Read More
PROTACs targeting CDK12 and/or a CDK9 synthesized at the Dana-Farber Cancer Institute
Read More
JAK inhibitor prodrugs discovered at Theravance Biopharma
Read More
Beta Pharma identifies new HCV NS5A inhibitors
Read More
Supemtek quadrivalent recombinant influenza vaccine approved in E.U.
Read More
Preliminary phase I data for the half-life extended BiTE immune therapy, AMG-757
Read More
Bioventus receives IND clearance to study PTP-001 for knee osteoarthritis
Read More
FDA clears initiation of phase I trial of anti-LILRB2/ILT4 antibody JTX-8064
Read More
Synergy seen for DA-1241 with DPP4 inhibitor for the treatment of NASH
Read More
BioVersys initiates phase I testing of BV-100 for carbapenem-resistant A. baumannii infections
Read More
Interim data from phase Ib/IIa study of VBI-2601 for chronic hepatitis B
Read More
Genoscience completes phase Ib study of GNS-561 in primary and secondary liver cancer
Read More